Life sciences venture capital (VC) firm Omega Funds has closed its eighth fund, with capital commitments totalling $647m.

The US Court of Appeals has overturned a $106.5m ruling wherein a California court jury found that Medtronic infringed on a heart valve replacement method developed by Colibri Heart Valve.

DeepQure has secured approval from South Korea's MFDS for the trial of its HyperQure, aimed at treating atrial fibrillation (AF).

RadNet's subsidiary DeepHealth has concluded the previously announced acquisition of iCAD in a deal valued at $103m.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).

The medical device industry faces being pulled into a broader contest over control, sovereignty and industrial self-sufficiency.

Charlie Whelan, a Senior Director of Consulting at GlobalData, discusses the latest trends in medical devices for 2025.

Xeltis has reported positive preliminary data for its Xabg coronary artery bypass conduit (CABG) in a trial that is underway at EU sites.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

UroMems is set to enter the pivotal trial phase with its device for treating stress urinary incontinence (SUI).